ELDN Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates Amid Ongoing Development Costs MSN Q1 2024 Earnings Narrowing Losses Amid Limited Revenue Disclosure Stock Surges 2026 CTOR Q1 2026 Earnings EPS Falls Far Below Estimates as PreRevenue Company Continues RD Investment GWAV Q3 2023 Earnings Negative EPS Reported Stock Rises 225 CTSO Q1 2026 Earnings Loss Widens as EPS Misses Estimates Stock Gains 642 GALT Q1 2026 Earnings EPS Misses Estimates as Clinical Development Continues